Anderson Karen M.
Insider CIK 1762176 · MIME Chief Human Resources Officer · CNTA Chief People Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 75,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 117,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 28,336 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 83,924 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 120,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer | 2026-06-24 | 2026-06-24 | 62,085 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2026-03-26 | 2026-03-27 | 41,076 | — | $0 | 83,924 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2026-03-26 | 2026-03-27 | 41,076 | $8.01 | $329.0K | 103,161 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2026-03-26 | 2026-03-27 | 41,076 | $30.12 | $1.24M | 62,085 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2026-03-17 | 2026-03-18 | 10,043 | — | $0 | 75,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2026-03-17 | 2026-03-18 | 10,043 | $4.01 | $40.3K | 72,128 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2026-03-17 | 2026-03-18 | 10,043 | $28.10 | $282.2K | 62,085 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2026-03-16 | 2026-03-18 | 64,768 | — | $0 | 85,043 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2026-03-16 | 2026-03-18 | 64,768 | $28.21 | $1.83M | 62,085 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2026-03-16 | 2026-03-18 | 64,768 | $4.01 | $259.7K | 126,853 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2026-03-13 | 2026-03-13 | 109,398 | — | $0 | 134,637 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2026-03-13 | 2026-03-16 | 94,224 | — | $0 | 149,811 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2026-03-13 | 2026-03-16 | 15,174 | — | $0 | 28,336 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2026-03-13 | 2026-03-13 | 12,068 | $27.13 | $327.4K | 62,085 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2026-03-13 | 2026-03-13 | 107,961 | $26.15 | $2.82M | 74,153 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2026-03-13 | 2026-03-13 | 109,398 | $4.01 | $438.7K | 182,114 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2026-03-13 | 2026-03-16 | 15,174 | $3.85 | $58.4K | 182,114 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2026-03-13 | 2026-03-16 | 12,068 | $27.13 | $327.4K | 62,085 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2026-03-13 | 2026-03-16 | 107,961 | $26.15 | $2.82M | 74,153 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2026-03-13 | 2026-03-16 | 94,224 | $4.01 | $377.8K | 166,940 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2026-02-02 | 2026-02-03 | 117,000 | — | $0 | 117,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2026-02-02 | 2026-02-03 | 29,000 | — | $0 | 72,716 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2026-02-01 | 2026-02-03 | 10,606 | $24.57 | $260.6K | 43,716 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-02-10 | 2025-02-10 | 429 | — | $0 | 244,035 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-02-10 | 2025-02-10 | 429 | $4.01 | $1.7K | 54,751 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-02-10 | 2025-02-10 | 429 | $18.99 | $8.1K | 54,322 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-02-07 | 2025-02-10 | 30,526 | — | $0 | 244,464 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-02-07 | 2025-02-10 | 30,526 | $19.03 | $580.9K | 54,322 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-02-07 | 2025-02-10 | 30,526 | $4.01 | $122.4K | 84,848 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2025-02-03 | 2025-02-04 | 120,000 | — | $0 | 120,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-02-03 | 2025-02-04 | 6,471 | $16.86 | $109.1K | 54,322 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2025-02-01 | 2025-02-04 | 10,732 | $16.92 | $181.6K | 60,793 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2024-12-17 | 2024-12-17 | 10,624 | — | $0 | 43,510 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-12-17 | 2024-12-17 | 10,624 | $17.32 | $184.0K | 71,525 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2024-12-17 | 2024-12-17 | 10,624 | $3.85 | $40.9K | 82,149 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2024-12-13 | 2024-12-17 | 5,876 | — | $0 | 54,134 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2024-12-13 | 2024-12-17 | 5,876 | $3.85 | $22.6K | 77,401 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-12-13 | 2024-12-17 | 5,876 | $17.01 | $100.0K | 71,525 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2024-03-25 | 2024-03-26 | 25,010 | — | $0 | 274,990 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2024-03-25 | 2024-03-26 | 19,990 | — | $0 | 60,010 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-03-25 | 2024-03-26 | 21,165 | $12.21 | $258.4K | 71,525 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2024-03-25 | 2024-03-26 | 25,010 | $4.01 | $100.3K | 102,695 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2024-03-25 | 2024-03-26 | 19,990 | $3.85 | $77.0K | 122,685 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-03-25 | 2024-03-26 | 29,995 | $11.66 | $349.7K | 92,690 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2024-02-01 | 2024-02-02 | 125,000 | — | $0 | 125,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-02-01 | 2024-02-02 | 7,265 | $8.19 | $59.5K | 77,685 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2024-02-01 | 2024-02-02 | 31,250 | — | $0 | 84,950 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2023-02-01 | 2023-02-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2023-02-01 | 2023-02-03 | 53,700 | — | $0 | 53,700 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2022-12-01 | 2022-12-05 | 300,000 | — | $0 | 300,000 | SEC↗ |
| MIME Mimecast Ltd | D To issuer deriv | 2022-05-19 | 2022-05-23 | 18,594 | — | $0 | 0 | SEC↗ |
| MIME Mimecast Ltd | D To issuer deriv | 2022-05-19 | 2022-05-23 | 39,066 | — | $0 | 0 | SEC↗ |
| MIME Mimecast Ltd | D To issuer deriv | 2022-05-19 | 2022-05-23 | 26,602 | — | $0 | 0 | SEC↗ |
| MIME Mimecast Ltd | D To issuer | 2022-05-19 | 2022-05-23 | 6,250 | — | $0 | 0 | SEC↗ |
| MIME Mimecast Ltd | D To issuer | 2022-05-19 | 2022-05-23 | 6,366 | — | $0 | 0 | SEC↗ |
| MIME Mimecast Ltd | D To issuer | 2022-05-19 | 2022-05-23 | 9,180 | — | $0 | 0 | SEC↗ |
| MIME Mimecast Ltd | D To issuer | 2022-05-19 | 2022-05-23 | 9,400 | — | $0 | 0 | SEC↗ |
| MIME Mimecast Ltd | D To issuer | 2022-05-19 | 2022-05-23 | 8,649 | — | $0 | 0 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2022-04-01 | 2022-04-04 | 4,316 | — | $0 | 8,649 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2022-04-01 | 2022-04-04 | 2,068 | — | $0 | 9,180 | SEC↗ |
| MIME Mimecast Ltd | F Tax w/h | 2022-04-01 | 2022-04-04 | 991 | $79.59 | $78.9K | 11,248 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2022-04-01 | 2022-04-04 | 2,248 | — | $0 | 6,366 | SEC↗ |
| MIME Mimecast Ltd | F Tax w/h | 2022-04-01 | 2022-04-04 | 935 | $79.59 | $74.4K | 8,614 | SEC↗ |
| MIME Mimecast Ltd | F Tax w/h | 2022-02-01 | 2022-02-02 | 1,917 | $79.74 | $152.9K | 10,583 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2022-02-01 | 2022-02-02 | 4,333 | — | $0 | 6,250 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2022-02-01 | 2022-02-02 | 4,333 | — | $0 | 4,333 | SEC↗ |
| MIME Mimecast Ltd | M Exercise deriv | 2021-11-01 | 2021-11-03 | 7,812 | — | $0 | 39,066 | SEC↗ |
| MIME Mimecast Ltd | S Sale | 2021-11-01 | 2021-11-03 | 459 | $75.92 | $34.8K | 145 | SEC↗ |
| MIME Mimecast Ltd | S Sale | 2021-11-01 | 2021-11-03 | 7,208 | $75.02 | $540.7K | 604 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2021-11-01 | 2021-11-03 | 7,812 | $40.00 | $312.5K | 7,812 | SEC↗ |
| MIME Mimecast Ltd | S Sale | 2021-11-01 | 2021-11-03 | 145 | $76.51 | $11.1K | 0 | SEC↗ |
| MIME Mimecast Ltd | M Exercise deriv | 2021-10-01 | 2021-10-04 | 1,859 | — | $0 | 18,594 | SEC↗ |
| MIME Mimecast Ltd | S Sale | 2021-10-01 | 2021-10-04 | 968 | $64.25 | $62.2K | 891 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2021-10-01 | 2021-10-04 | 1,859 | $33.38 | $62.1K | 1,859 | SEC↗ |
| MIME Mimecast Ltd | S Sale | 2021-10-01 | 2021-10-04 | 891 | $65.20 | $58.1K | 0 | SEC↗ |
| MIME Mimecast Ltd | M Exercise deriv | 2021-08-10 | 2021-08-12 | 1,859 | — | $0 | 20,453 | SEC↗ |
| MIME Mimecast Ltd | M Exercise deriv | 2021-08-10 | 2021-08-12 | 15,624 | — | $0 | 46,878 | SEC↗ |
| MIME Mimecast Ltd | S Sale | 2021-08-10 | 2021-08-12 | 1,002 | $59.05 | $59.2K | 0 | SEC↗ |
| MIME Mimecast Ltd | S Sale | 2021-08-10 | 2021-08-12 | 16,481 | $58.54 | $964.8K | 1,002 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2021-08-10 | 2021-08-12 | 15,624 | $40.00 | $625.0K | 15,624 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2021-08-10 | 2021-08-12 | 1,859 | $33.38 | $62.1K | 17,483 | SEC↗ |
| MIME Mimecast Ltd | A Award | 2021-07-01 | 2021-07-06 | 9,400 | — | $0 | 9,400 | SEC↗ |
| MIME Mimecast Ltd | M Exercise deriv | 2021-06-15 | 2021-06-16 | 7,437 | — | $0 | 22,312 | SEC↗ |
| MIME Mimecast Ltd | M Exercise deriv | 2021-06-15 | 2021-06-16 | 9,265 | — | $0 | 62,502 | SEC↗ |
| MIME Mimecast Ltd | S Sale | 2021-06-15 | 2021-06-16 | 21,067 | $52.20 | $1.10M | 0 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2021-06-15 | 2021-06-16 | 7,437 | $33.38 | $248.2K | 21,067 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2021-06-15 | 2021-06-16 | 9,265 | $40.00 | $370.6K | 13,630 | SEC↗ |
| MIME Mimecast Ltd | M Exercise deriv | 2021-06-14 | 2021-06-16 | 13,530 | — | $0 | 71,767 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2021-06-14 | 2021-06-16 | 13,530 | $40.00 | $541.2K | 17,895 | SEC↗ |
| MIME Mimecast Ltd | S Sale | 2021-06-14 | 2021-06-16 | 13,530 | $52.02 | $703.8K | 4,365 | SEC↗ |
| MIME Mimecast Ltd | M Exercise deriv | 2021-06-11 | 2021-06-14 | 7,735 | — | $0 | 85,297 | SEC↗ |
| MIME Mimecast Ltd | S Sale | 2021-06-11 | 2021-06-14 | 7,735 | $52.02 | $402.4K | 4,365 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2021-06-11 | 2021-06-14 | 7,735 | $40.00 | $309.4K | 12,100 | SEC↗ |
| MIME Mimecast Ltd | M Exercise deriv | 2021-06-10 | 2021-06-14 | 27,654 | — | $0 | 93,032 | SEC↗ |
| MIME Mimecast Ltd | S Sale | 2021-06-10 | 2021-06-14 | 27,654 | $52.19 | $1.44M | 4,365 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2021-06-10 | 2021-06-14 | 27,654 | $40.00 | $1.11M | 32,019 | SEC↗ |
| MIME Mimecast Ltd | M Exercise deriv | 2021-06-09 | 2021-06-10 | 4,314 | — | $0 | 120,686 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2021-06-09 | 2021-06-10 | 4,314 | $40.00 | $172.6K | 8,679 | SEC↗ |
| MIME Mimecast Ltd | S Sale | 2021-06-09 | 2021-06-10 | 4,314 | $51.99 | $224.3K | 4,365 | SEC↗ |
| MIME Mimecast Ltd | S Sale | 2021-04-05 | 2021-04-07 | 2,248 | $40.75 | $91.6K | 4,365 | SEC↗ |
| MIME Mimecast Ltd | A Award deriv | 2021-04-01 | 2021-04-05 | 26,602 | — | $0 | 26,602 | SEC↗ |
| MIME Mimecast Ltd | F Tax w/h | 2021-04-01 | 2021-04-05 | 935 | $40.85 | $38.2K | 11,797 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2021-04-01 | 2021-04-05 | 2,248 | — | $0 | 6,613 | SEC↗ |
| MIME Mimecast Ltd | A Award | 2021-04-01 | 2021-04-05 | 12,239 | — | $0 | 12,239 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2021-04-01 | 2021-04-05 | 2,248 | — | $0 | 9,549 | SEC↗ |
| MIME Mimecast Ltd | S Sale | 2021-02-02 | 2021-02-03 | 55 | $45.78 | $2.5K | 4,365 | SEC↗ |
| MIME Mimecast Ltd | S Sale | 2021-02-02 | 2021-02-03 | 4,243 | $45.15 | $191.6K | 4,420 | SEC↗ |
| MIME Mimecast Ltd | F Tax w/h | 2021-02-01 | 2021-02-03 | 1,952 | $44.45 | $86.8K | 16,798 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2021-02-01 | 2021-02-03 | 4,298 | — | $0 | 8,663 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2021-02-01 | 2021-02-03 | 4,298 | — | $0 | 12,500 | SEC↗ |
| MIME Mimecast Ltd | A Award deriv | 2020-04-01 | 2020-04-01 | 29,749 | — | $0 | 29,749 | SEC↗ |
| MIME Mimecast Ltd | A Award | 2020-04-01 | 2020-04-01 | 12,732 | — | $0 | 12,732 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2020-02-02 | 2020-02-03 | 4,365 | — | $0 | 18,750 | SEC↗ |
| MIME Mimecast Ltd | F Tax w/h | 2020-02-01 | 2020-02-03 | 1,885 | $51.03 | $96.2K | 23,115 | SEC↗ |
| MIME Mimecast Ltd | M Exercise | 2020-02-01 | 2020-02-03 | 4,365 | — | $0 | 4,365 | SEC↗ |
| MIME Mimecast Ltd | A Award deriv | 2019-02-01 | 2019-02-04 | 125,000 | — | $0 | 125,000 | SEC↗ |
| MIME Mimecast Ltd | A Award | 2019-02-01 | 2019-02-04 | 25,000 | — | $0 | 25,000 | SEC↗ |